Sabby Volatility Exits RedHill Biopharma, Now Owns 0% of ADSs
Ticker: RDHL · Form: SC 13G/A · Filed: Jan 2, 2024 · CIK: 1553846
| Field | Detail |
|---|---|
| Company | Redhill Biopharma Ltd. (RDHL) |
| Form Type | SC 13G/A |
| Filed Date | Jan 2, 2024 |
| Risk Level | medium |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: institutional-ownership, divestment, SC-13G/A, biopharma
TL;DR
**Sabby Volatility just dumped all its RedHill Biopharma shares.**
AI Summary
Sabby Volatility Warrant Master Fund, Ltd. filed an amended SC 13G/A on January 2, 2024, indicating they no longer beneficially own any shares of RedHill Biopharma Ltd. as of December 31, 2023. This update shows a complete divestment from the biopharmaceutical company, as their aggregate beneficial ownership has dropped to 0 shares, representing 0% of the class. This matters to investors because a significant institutional holder has exited their position, which could signal a lack of confidence in RedHill Biopharma's future prospects.
Why It Matters
This filing signals a complete divestment by Sabby Volatility Warrant Master Fund, Ltd., which could be interpreted as a loss of institutional confidence in RedHill Biopharma Ltd.'s stock.
Risk Assessment
Risk Level: medium — The complete divestment by an institutional investor could indicate underlying concerns about the company's future, posing a medium risk to current or prospective shareholders.
Analyst Insight
A smart investor would consider this complete divestment by Sabby Volatility Warrant Master Fund, Ltd. as a potential red flag and conduct further due diligence into RedHill Biopharma Ltd.'s fundamentals and future prospects before making any investment decisions.
Key Numbers
- 0 — Aggregate Shares Beneficially Owned (Sabby Volatility Warrant Master Fund, Ltd. now owns zero shares of RedHill Biopharma Ltd.)
- 0% — Percent of Class Owned (Sabby Volatility Warrant Master Fund, Ltd. no longer holds any percentage of RedHill Biopharma Ltd.'s ADSs.)
Key Players & Entities
- Sabby Volatility Warrant Master Fund, Ltd. (company) — reporting person who filed the SC 13G/A
- RedHill Biopharma Ltd. (company) — the issuer of the securities
- December 31, 2023 (date) — date of event requiring the filing
- 0 (dollar_amount) — aggregate amount of shares beneficially owned
- 0% (dollar_amount) — percent of class represented by amount owned
Forward-Looking Statements
- RedHill Biopharma Ltd.'s stock price may experience downward pressure due to the institutional divestment. (RedHill Biopharma Ltd.) — medium confidence, target: Q1 2024
- Other institutional investors might re-evaluate their positions in RedHill Biopharma Ltd. following this exit. (RedHill Biopharma Ltd.) — low confidence, target: Q1 2024
FAQ
Who filed this SC 13G/A amendment?
The SC 13G/A amendment was filed by Sabby Volatility Warrant Master Fund, Ltd., as indicated in the 'NAME OF REPORTING PERSONS' section of the filing.
What is the subject company of this filing?
The subject company is RedHill Biopharma Ltd., identified as the 'Name of Issuer' in the Schedule 13G.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as stated in the Schedule 13G.
How many shares does Sabby Volatility Warrant Master Fund, Ltd. now beneficially own in RedHill Biopharma Ltd.?
Sabby Volatility Warrant Master Fund, Ltd. now beneficially owns 0 shares of RedHill Biopharma Ltd., as shown in 'AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON' (Row 9) on the cover page.
What percentage of RedHill Biopharma Ltd.'s class of securities does Sabby Volatility Warrant Master Fund, Ltd. now represent?
Sabby Volatility Warrant Master Fund, Ltd. now represents 0% of RedHill Biopharma Ltd.'s class of securities, as indicated in 'PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)' (Row 11) on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 2, 2024 regarding RedHill Biopharma Ltd. (RDHL).